Answers are grounded in this paper and cite their sources.
TDP-43 proteinopathies encompass most cases of sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), among other disorders. Their shared pathological hallmarks are nuclear clearance and cytoplasmic mislocalization of TDP-43. The established model of nuclear loss of function coupled with cytoplasmic gain of toxicity accounts well for disease progression. However, it does not identify where the pathological cycle begins, and it cannot readily explain why comparable aggregation burdens produce markedly divergent clinical phenotypes. In this article, nucleocytoplasmic transport dysfunction is further decomposed into three distinguishable fluxes: reduced nuclear import efficiency, impaired nuclear retention, and a relative enhancement of nuclear export/passive diffusion. Together, these three fluxes produce a persistent net displacement of the nucleocytoplasmic distribution toward the cytoplasmic side. We term this displacement “cytoplasmic bias” and define it as a quantifiable, falsifiable upstream variable that is independent of aggregation morphology. Integrating structural, cellular, human induced pluripotent stem cell (iPSC)-derived neuronal, and biomarker evidence, we propose the following sequence. Cytoplasmic bias converts native 3′UTR-mediated autoregulation into maladaptive feedback. This feedback induces loss of nuclear splicing function and shunts TDP-43 into cytoplasmic insoluble and phase-separated compartments. “Export bias” and “import blockade” are predicted to produce distinct consequences, and soluble oligomerization, together with loss of cryptic exon repression, may precede symptom onset. We also delineate the evidentiary boundaries of this proposal: the most direct evidence comes from low-burden engineered NES/NLS models that retain autoregulation. In contrast, it remains to be directly tested whether cytoplasmic bias precedes and is independent of aggregation in sporadic disease and in the human brain. On this basis, we reconstruct the causal chain from physiological nucleocytoplasmic homeostasis to the pathological cascade, clarify the directionality linking upstream driving, phase-separation amplification, and downstream injury, and provide testable predictions and therapeutic windows for subsequent studies to falsify or refine.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: